Regenerative Medicine in Lithuania
A Guide for International Patients

This guide explains what is available, who delivers it, how it is regulated, and what to expect if you are considering treatment.

A small country with a serious science base

Lithuania is a member state of the European Union, a member of NATO, and operates its medical system under EU regulatory standards. The country has a long-standing biomedical research tradition rooted in Vilnius University and the Vilnius University Hospital network, with strong ties to European research consortia.

For international patients, this matters because treatment in Lithuania is administered under a specific, verifiable regulatory framework, not outside of any framework. Innovita Clinic operates under Lithuanian License 4094, issued by Lithuania's national medical regulator, and is bound by EU medical practice standards.

Innovita Clinic, the clinical destination

Innovita Clinic is the licensed private clinic in Vilnius where treatments are administered. It operates across three main areas: immunotherapy (including oncology support), regenerative medicine, and general medicine. The clinic combines a multidisciplinary specialist team with on-site cell therapy, IV therapy, and procedural capabilities.

The clinic is located at Suduviu g. 74 in the Antezeriai district of Vilnius and serves both Lithuanian and international patients.

Immunotherapy and Oncology Support

Cytokine-Activated Natural Killer (NK) Cell Therapy. NK cells are part of the body's innate immune system. Cytokine-activated NK cell therapy involves expanding and activating a patient's own NK cells outside the body and reinfusing them, with the goal of strengthening the body's response against cancer cells.

Dendritic Cell Vaccines. Dendritic cells are immune cells that present antigens and direct the adaptive immune response. Dendritic cell vaccines are a personalized immunotherapy used in oncology and developed from the patient's own cells.

Autoimmune Disease Protocols. Innovita treats autoimmune conditions through immune-modulating protocols, sometimes combined with regenerative therapies depending on the case.

Post-Chemotherapy Support and Oncological Kinesiotherapy. Supportive care and rehabilitation for patients during and after conventional cancer treatment.

Regenerative Medicine

MSC Stem Cell Therapy. Mesenchymal stem cells delivered intravenously, into joints, or into the spine depending on the condition. Used in research and clinical contexts for autoimmune conditions, musculoskeletal injury, neurological conditions, and inflammatory disease.

Adipose-Derived Stem Cells (Fat Stem Cells). Stem cells harvested from the patient's own adipose tissue, used in regenerative protocols for orthopedic, aesthetic, and systemic applications.

MSC-Derived Exosome Therapy. Exosomes are nanoscale extracellular vesicles released by stem cells that carry signaling molecules, growth factors, and genetic material. Delivery routes include intravenous infusion, intranasal drops or nebulizer (for blood-brain barrier crossing), and local administration alongside MSC injections.

Peptide Protocols

Personalized peptide protocols target longevity, recovery, immune modulation, cognitive function, and tissue repair. Common compounds include BPC-157, TB-500, Epitalon, MOTS-c, AC-Selank-NH2, AC-Semax-NH2, and others, prescribed individually based on the patient's clinical picture and goals.

IV Therapy and Biologics

NAD+, glutathione, high-dose vitamin C, cord blood plasma, concentrated growth factor (CGF), and supportive infusions are used both as standalone protocols and as adjuncts to stem cell, exosome, or immunotherapy treatment.

Combined Protocols

Most international patients receive combination protocols rather than single-modality treatment. A typical structure might combine an IV stem cell infusion with localized exosomes, a peptide protocol shipped home for continuation, and follow-up support.

The Innovita medical team

Treatments are administered by licensed Lithuanian physicians at Innovita Clinic. The clinic's specialist team includes neurosurgery, vascular surgery, oncology (chemotherapy and radiotherapy), orthopedics and traumatology, and dermatovenerology, alongside dedicated immunotherapy and regenerative medicine clinicians. The clinic operates under Lithuanian License 4094 and EU medical practice standards.

Dr. Adas Darinskas, PhD

Dr. Darinskas leads the scientific direction of the regenerative and immunotherapy protocols at Innovita. He holds a PhD in immunology and has more than two decades of research experience in immune cell therapies, including dendritic cell vaccines, cytokine-induced killer cell therapy, and stem cell applications. He is published in peer-reviewed regenerative medicine and immunology literature.

For international patients, Dr. Darinskas is involved in the clinical consultation prior to travel, reviews medical records, and contributes to the design of the treatment protocol.

Strong Craft Regen and Innovita

Strong Craft Regen is a direct partner of Innovita Clinic, providing the logistical backbone for international client engagement and coordination. We handle the whole patient journey: discovery call, medical record review, scheduling, communication with the Vilnius team, and post-treatment support.

Stage 1: Discovery call

A 30-45 minute conversation with Jed Ryan to understand your specific situation, see if the services we have access to could benefit your current medical situation or longevity goals, and decide together whether this direction is worth exploring further.

Stage 2: Records review and scientific consultation

You send your medical records: recent bloodwork, imaging, specialist reports, medication list. Our team prepares a clinical brief and organizes a Zoom consultation. Zoom consultations are held weekly. The appropriate medical staff will review your case directly with you and outline the proposed treatment approach.

Stage 3: Treatment plan and quote

Following the Zoom consult, the medical team issues a detailed treatment plan. We produce a quote, discuss all treatment costs, and discuss travel and accommodation. We give recommendations and help with planning for your time in Vilnius.

Stage 4: Travel and treatment

You travel to Vilnius for the treatment window. Stay length is typically 2-3 days, longer for multi-stage protocols.

Stage 5: Continuation and follow-up

Our team maintains continuous care following treatment, with scheduled touchpoints to ensure the patient is progressing as hoped.

Getting to Vilnius

Vilnius International Airport (VNO) is served by direct flights from major European hubs including London, Frankfurt, Amsterdam, Warsaw, Helsinki, and Copenhagen. From North America, most patients connect via London, Frankfurt, or Helsinki.

Typical travel times:

• From London: ~3 hours direct
• From Frankfurt: ~2 hours direct
• From New York: ~10-12 hours via one connection
• From Toronto: ~10-12 hours via one connection

Ground transportation

We offer a full driver service for international patients, which includes:

• Pickup from Vilnius International Airport
• Transfer to your hotel
• Round-trip transport between hotel and clinic on treatment days

The driver service is €250 for the duration of your stay.

If you'd prefer to arrange your own transport, you can rent a vehicle, or use Bolt (the European equivalent of Uber). The Bolt app is straightforward to download and rides across Vilnius are inexpensive.

Where to stay

Most international patients stay in the Old Town (Senamiestis) or near the city center, both of which offer easy access to the clinic and a walkable historic core. Hotels we recommend based on guest experience:

The clinic is approximately 10-15 minutes by car from any of these.

Food

Food in central Vilnius is excellent. The Old Town and the Užupis district have a strong restaurant culture, with everything from traditional Lithuanian cuisine to modern European, Italian, Japanese, and Middle Eastern options. Most restaurants carry English menus and many have international staff. We're happy to share specific recommendations once we know your preferences.

Communication

English is widely spoken in medical and hospitality contexts in Vilnius, including throughout Innovita Clinic and the Strong Craft Regen network. Most logistical communication happens in advance via email and Zoom; in-person communication during treatment is straightforward.

This is the section international patients most often ask about. We aim to be direct rather than reassuring.

For US patients

In the United States, the FDA has not approved most MSC or exosome products outside specific contexts such as umbilical cord blood for blood disorders. The FDA has issued consumer alerts about regenerative medicine claims and emphasizes that most stem cell and exosome products marketed in the US are not FDA-approved.

Patients who travel to Lithuania for treatment do so under EU and Lithuanian regulation, not under FDA jurisdiction. This is a different regulatory framework, with different evidence and authorization requirements. We do not represent that any treatment available in Vilnius is FDA-approved or available in the US.

For more detail, see our page for US patients.

For Canadian patients

Health Canada considers most cell therapies investigational and requires authorization for domestic administration. Canadian patients who pursue regenerative medicine internationally do so under the regulatory framework of the country where treatment is administered.

For more detail, see our page for Canadian patients.

For European patients

Lithuania is an EU member state. Treatment at Innovita Clinic is administered under Lithuanian License 4094 and EU medical practice standards. Advanced therapy products fall under the EMA's ATMP regulatory framework.

For European patients, this is the same regulatory environment that governs medical care across the EU, not a foreign or unregulated system.

For more detail, see our page for European patients.

Detailed answers to the questions international patients ask most are on our FAQ page, covering treatment safety, medical records, regulation and clinic licensing, treatment costs and how pricing works, and the full journey from first call to follow-up care.